| Year |
Citation |
Score |
| 2006 |
Odegard VH, Schatz DG. Targeting of somatic hypermutation. Nature Reviews. Immunology. 6: 573-83. PMID 16868548 DOI: 10.1038/Nri1896 |
0.448 |
|
| 2006 |
Inlay MA, Gao HH, Odegard VH, Lin T, Schatz DG, Xu Y. Roles of the Ig kappa light chain intronic and 3' enhancers in Igk somatic hypermutation. Journal of Immunology (Baltimore, Md. : 1950). 177: 1146-51. PMID 16818772 DOI: 10.4049/Jimmunol.177.2.1146 |
0.454 |
|
| 2005 |
Rush JS, Liu M, Odegard VH, Unniraman S, Schatz DG. Expression of activation-induced cytidine deaminase is regulated by cell division, providing a mechanistic basis for division-linked class switch recombination. Proceedings of the National Academy of Sciences of the United States of America. 102: 13242-7. PMID 16141332 DOI: 10.1073/Pnas.0502779102 |
0.452 |
|
| 2005 |
Odegard VH, Kim ST, Anderson SM, Shlomchik MJ, Schatz DG. Histone modifications associated with somatic hypermutation. Immunity. 23: 101-10. PMID 16039583 DOI: 10.1016/J.Immuni.2005.05.007 |
0.403 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2015 |
Bashour KT, Larson RP, Graef P, Stemberger C, Lothar G, Odegard V, Ramsborg CG. Functional Characterization of a T Cell Stimulation Reagent for the Production of Therapeutic Chimeric Antigen Receptor T Cells Blood. 126: 1901-1901. DOI: 10.1182/blood.V126.23.1901.1901 |
0.219 |
|
| 2020 |
Metz H, Childs M, Brevik J, Winship D, Brender T, Comeau M, Moyes K, Chang J, Adamo J, Setter B, Xu H, Fan L, Smith S, Tan P, DuBose R, ... ... Odegard V, et al. SBT6050, a HER2-directed TLR8 therapeutic, as a systemically administered, tumor-targeted human myeloid cell agonist. Journal of Clinical Oncology. 38: 3110-3110. DOI: 10.1200/jco.2020.38.15_suppl.3110 |
0.205 |
|
| 2015 |
Larson RP, Ports M, Jessup H, Manriquez G, Hay C, Stewart R, Rebelatto M, Hollingsworth R, Odegard V. Preclinical Analyses Support Clinical Investigation of Combined PD-L1 Blockade and Anti-CD19 CAR T Cell Therapy for the Treatment of NHL Blood. 126: 5430-5430. DOI: 10.1182/blood.V126.23.5430.5430 |
0.145 |
|
| 2013 |
Cox JH, Hussell S, Søndergaard H, Roepstorff K, Bui JV, Deer JR, Zhang J, Li ZG, Lamberth K, Kvist PH, Padkjær S, Haase C, Zahn S, Odegard VH. Antibody-mediated targeting of the Orai1 calcium channel inhibits T cell function. Plos One. 8: e82944. PMID 24376610 DOI: 10.1371/journal.pone.0082944 |
0.138 |
|
| 2013 |
Blasius AL, Beilke JN, Blumberg H, Bui J, Cox JH, Cox T, Jessup HJ, Kong PL, Levin SD, Odegard VH, Smith PS, Stucky JA, Thomas EP, Wahle JA, Rømer J. AB0036 Il-20 targets local tissue inflammation as opposed to systemic inflammation Annals of the Rheumatic Diseases. 72: A796.3-A797. DOI: 10.1136/annrheumdis-2013-eular.2359 |
0.087 |
|
| Hide low-probability matches. |